Terms: = Pancreatic cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Prognosis
83 results:
1. Relationship Between Immunophenotypes, Genetic Profiles, and Clinicopathologic Characteristics in Small Bowel Adenocarcinoma.
Hoshimoto A; Tatsuguchi A; Yamada T; Kuriyama S; Hamakubo R; Nishimoto T; Omori J; Akimoto N; Gudis K; Mitsui K; Tanaka S; Fujimori S; Hatori T; Shimizu A; Iwakiri K
Am J Surg Pathol; 2024 Feb; 48(2):127-139. PubMed ID: 38062562
[TBL] [Abstract] [Full Text] [Related]
2. pancreatic ductal adenocarcinoma with acinar-to-ductal metaplasia-like cancer cells shows increased cellular proliferation.
Nishimon R; Yoshida K; Sanuki F; Nakashima Y; Miyake T; Sato T; Tomiyama Y; Nishina S; Moriya T; Shiotani A; Hino K
Pancreatology; 2023 Nov; 23(7):811-817. PubMed ID: 37659916
[TBL] [Abstract] [Full Text] [Related]
3. The prognostic role of epidermal growth factor receptor mutation in completely resected ampullary adenocarcinoma.
Varol U; Cakır E; Aktas S; Altun ZS; Dilek FH; Butun O; Salman T; Unlu AGD; Alacacioglu A; Somali I
Pol J Pathol; 2023; 74(1):18-28. PubMed ID: 37306349
[TBL] [Abstract] [Full Text] [Related]
4. Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of pancreatic cancer Cells Through Inhibition of muc1 Expression.
Wei D; Wang L; Liu Y; Hafley MA; Tan L; Lorenzi PL; Yang P; Zuo X; Bresalier RS
Dig Dis Sci; 2023 Jul; 68(7):3043-3058. PubMed ID: 37071246
[TBL] [Abstract] [Full Text] [Related]
5. Atypical Mucin Expression Predicts Worse Overall Survival in Resectable pancreatic Ductal Adenocarcinoma.
Qian Y; Gong Y; Liu Y; Chen Y; Wang R; Dai Z; Zou X; Tasiheng Y; Luo G; Lin X; Wang X; Cheng H; Yu X; Liu C
J Immunol Res; 2022; 2022():7353572. PubMed ID: 35910854
[TBL] [Abstract] [Full Text] [Related]
6. Association of mucin family members with prognostic significance in pancreatic cancer patients: A meta-analysis.
Xu W; Zhang M; Liu L; Yin M; Xu C; Weng Z
PLoS One; 2022; 17(6):e0269612. PubMed ID: 35709153
[TBL] [Abstract] [Full Text] [Related]
7. Integrated Analysis of Multi-Omics Data to Identify Prognostic Genes for pancreatic cancer.
Jiang F; Huang X; Zhang F; Pan J; Wang J; Hu L; Chen J; Wang Y
DNA Cell Biol; 2022 Mar; 41(3):305-318. PubMed ID: 35104421
[TBL] [Abstract] [Full Text] [Related]
8. Baseline immunity predicts prognosis of pancreatic cancer patients treated with WT1 and/or muc1 peptide-loaded dendritic cell vaccination and a standard chemotherapy.
Ota S; Miyashita M; Yamagishi Y; Ogasawara M
Hum Vaccin Immunother; 2021 Dec; 17(12):5563-5572. PubMed ID: 34919493
[TBL] [Abstract] [Full Text] [Related]
9. muc1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas.
Luan Z; Morimoto Y; Fushimi A; Yamashita N; Suo W; Bhattacharya A; Hagiwara M; Jin C; Kufe D
Carcinogenesis; 2022 Feb; 43(1):67-76. PubMed ID: 34657147
[TBL] [Abstract] [Full Text] [Related]
10. IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of pancreatic cancer.
Markov SD; Caffrey TC; O'Connell KA; Grunkemeyer JA; Shin S; Hanson R; Patil PP; Shukla SK; Gonzalez D; Crawford AJ; Vance KE; Huang Y; Eberle KC; Radhakrishnan P; Grandgenett PM; Singh PK; Madiyalakan R; Daniels-Wells TR; Penichet ML; Nicodemus CF; Poole JA; Jaffee EM; Hollingsworth MA; Mehla K
Mol Cancer Ther; 2021 Dec; 20(12):2457-2468. PubMed ID: 34625505
[TBL] [Abstract] [Full Text] [Related]
11. Dendritic cell vaccination combined with a conventional chemotherapy for patients with relapsed or advanced pancreatic ductal adenocarcinoma: a single-center phase I/II trial.
Ogasawara M; Miyashita M; Yamagishi Y; Ota S
Ther Apher Dial; 2021 Aug; 25(4):415-424. PubMed ID: 33886156
[TBL] [Abstract] [Full Text] [Related]
12. A case of intraductal tubulopapillary neoplasm of the pancreas in a branch duct: a rare case report and literature review.
Yamaguchi A; Hamada T; Wada K; Moriuchi R; Tao K; Konishi H; Tamaru Y; Kusunoki R; Kuwai T; Kouno H; Ishiyama K; Hadano N; Sudo T; Toyota N; Zaitsu J; Kuraoka K; Kohno H
BMC Gastroenterol; 2021 Apr; 21(1):162. PubMed ID: 33849435
[TBL] [Abstract] [Full Text] [Related]
13. Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm.
Detlefsen S; Jakobsen M; Nielsen MFB; Klöppel G; Mortensen MB
Pathol Res Pract; 2021 Jan; 217():153312. PubMed ID: 33341087
[TBL] [Abstract] [Full Text] [Related]
14. Mucins in pancreatic cancer: A well-established but promising family for diagnosis, prognosis and therapy.
Wang S; You L; Dai M; Zhao Y
J Cell Mol Med; 2020 Sep; 24(18):10279-10289. PubMed ID: 32745356
[TBL] [Abstract] [Full Text] [Related]
15. Predicted prognosis of Patients with pancreatic cancer by Machine Learning.
Yokoyama S; Hamada T; Higashi M; Matsuo K; Maemura K; Kurahara H; Horinouchi M; Hiraki T; Sugimoto T; Akahane T; Yonezawa S; Kornmann M; Batra SK; Hollingsworth MA; Tanimoto A
Clin Cancer Res; 2020 May; 26(10):2411-2421. PubMed ID: 31992588
[TBL] [Abstract] [Full Text] [Related]
16. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract] [Full Text] [Related]
17. Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tmuc1-CAR T Cell Treatment against pancreatic Ductal Adenocarcinoma.
Yazdanifar M; Zhou R; Grover P; Williams C; Bose M; Moore LJ; Wu ST; Maher J; Dreau D; Mukherjee AP
Cells; 2019 Sep; 8(9):. PubMed ID: 31514488
[TBL] [Abstract] [Full Text] [Related]
18. Oncogenic and Non-Malignant pancreatic Exosome Cargo Reveal Distinct Expression of Oncogenic and Prognostic Factors Involved in Tumor Invasion and Metastasis.
Emmanouilidi A; Paladin D; Greening DW; Falasca M
Proteomics; 2019 Apr; 19(8):e1800158. PubMed ID: 30893511
[TBL] [Abstract] [Full Text] [Related]
19. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
[No Abstract] [Full Text] [Related]
20. Diagnostic and prognostic impact of mucin 1-6 expression in non-small cell lung cancer.
Sterlacci W; Fiegl M; Veits L; Tzankov A
Indian J Pathol Microbiol; 2018; 61(2):187-191. PubMed ID: 29676354
[TBL] [Abstract] [Full Text] [Related]
[Next]
